Paper36051345
Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB and 5 others. World J Gastroenterol, 2022. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide. Papers, record 36051345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36051345
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Parathyroid Hormone-Related Protein | Major topic |
| Animals | |
| Caco-2 Cells | |
| Cell Movement | |
| Cell Proliferation | |
| Humans | |
| Irinotecan | |
| Male | |
| Mice | |
| Trypan Blue |
Source PubMed
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19370057 | Pro-apoptotic effects of parathyroid hormone in intestinal cells. | Biochem Cell Biol | 2009 | https://conductscience.org/library/papers/19370057 | PubMed |
| 2 | 32418059 | Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis. | Apoptosis | 2020 | https://conductscience.org/library/papers/32418059 | PubMed |
| 3 | 32482024 | [Effect of silencing hepatocyte growth factor receptor c-Met expression on biological characteristics of colon cancer cells]. | Zhonghua Zhong Liu Za Zhi | 2020 | https://conductscience.org/library/papers/32482024 | PubMed |
| 4 | 29576428 | c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival. | Clin Colorectal Cancer | 2018 | https://conductscience.org/library/papers/29576428 | PubMed |
| 5 | 27843649 | Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells. | Genet Res Int | 2016 | https://conductscience.org/library/papers/27843649 | PubMed |
| 6 | 20361925 | (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells. | Arch Biochem Biophys | 2010 | https://conductscience.org/library/papers/20361925 | PubMed |
| 7 | 29394020 | Cisplatin and Oxaliplatin: Our Current Understanding of Their Actions. | Met Ions Life Sci | 2018 | https://conductscience.org/library/papers/29394020 | PubMed |
| 8 | 9933468 | Comparison of recombinant human PTH(1-34) (LY333334) with a C-terminally substituted analog of human PTH-related protein(1-34) (RS-66271): In vitro activity and in vivo pharmacological effects in rats. | J Bone Miner Res | 1999 | https://conductscience.org/library/papers/9933468 | PubMed |
| 9 | 31293052 | Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression. | Mol Oncol | 2019 | https://conductscience.org/library/papers/31293052 | PubMed |
| 10 | 32807225 | The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32807225 | PubMed |
| 11 | 22549910 | Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. | J Bone Miner Res | 2012 | https://conductscience.org/library/papers/22549910 | PubMed |
| 12 | 23876900 | Effect of c-Met inhibitor SU11274 on human colon cancer cell growth. | Chin Med J (Engl) | 2013 | https://conductscience.org/library/papers/23876900 | PubMed |
| 13 | 28342003 | Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression. | J Cancer Res Clin Oncol | 2017 | https://conductscience.org/library/papers/28342003 | PubMed |
| 14 | 14665611 | A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/14665611 | PubMed |
| 15 | 8651548 | Parathyroid hormone-related protein expression in the human colon: immunohistochemical evaluation. | Am Surg | 1996 | https://conductscience.org/library/papers/8651548 | PubMed |
| 16 | 27009393 | Targeting metastasis. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27009393 | PubMed |
| 17 | 32111984 | SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. | Oncogene | 2020 | https://conductscience.org/library/papers/32111984 | PubMed |
| 18 | 10934650 | Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893. | J Bone Miner Res | 2000 | https://conductscience.org/library/papers/10934650 | PubMed |
| 19 | 942051 | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. | Anal Biochem | 1976 | https://conductscience.org/library/papers/942051 | PubMed |
| 20 | 30415989 | E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity. | Clin Colorectal Cancer | 2019 | https://conductscience.org/library/papers/30415989 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42294316 | Study of ß-catenin signaling pathway modulated by PTHrP in cell and animal colorectal cancer models. | Front Oncol | 2026 | https://conductscience.org/library/papers/42294316 | PubMed |
| 40526090 | Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment. | Oncotarget | 2025 | https://conductscience.org/library/papers/40526090 | PubMed |
| 39958547 | Prognosis in stage II colon cancer: Expanding the horizons of risk factors. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/39958547 | PubMed |
| 37838928 | Parathyroid hormone-related protein as a potential prostate cancer biomarker: Promoting prostate cancer progression through upregulation of c-Met expression. | Biomol Biomed | 2024 | https://conductscience.org/library/papers/37838928 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36051345
GET https://conductscience.org/api/papers/v1/36051345/references?page=2